Tim McCarthy | LifeSci Advisors |
Sergio Traversa | Chief Executive Officer |
Chuck Ence | Chief Accounting and Compliance Officer |
Andrew Tsai | Jefferies |
Joon Lee | Truist |
Yatin Suneja | Guggenheim Partners |
Jay Olson | Oppenheimer |
Good afternoon, ladies and gentlemen. And thank you for standing by. Welcome to the Relmada Therapeutics Incorporated First Quarter 2021 Financial Results Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation.